Related Experiment Video

Updated: May 18, 2026

DNA Vector-based RNA Interference to Study Gene Function in Cancer
13:10

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

A review of RGD-functionalized nonviral gene delivery vectors for cancer therapy

J Park1, K Singha, S Son

  • 1Department of Chemistry, BK21 Program, Polymer Research Institute, Pohang University of Science and Technology (POSTECH), Pohang, Republic of Korea.

Cancer Gene Therapy
|September 29, 2012
PubMed

Insights

Targeted cancer gene therapy uses RGD-functionalized nonviral vectors to deliver genetic materials, inhibiting tumor growth and metastasis by targeting angiogenesis. This approach offers a promising strategy for effective cancer treatment.

Area of Science:

  • Biomedical Engineering
  • Oncology
  • Molecular Biology

Background:

  • Angiogenesis is critical for solid tumor growth and metastasis.
  • Antiangiogenic therapy offers a safe, non-invasive cancer treatment option.
  • Integrin receptors are overexpressed on angiogenic endothelial cells.

Purpose of the Study:

  • To review RGD-functionalized nonviral vectors for targeted cancer gene therapy.
  • To summarize progress and prospects in this therapeutic area.
  • To highlight applications in antiangiogenic therapy.

Main Methods:

  • Utilizing integrin-targeting peptides with arginine-glycine-aspartate (RGD) sequences.
  • Developing nonviral vectors for targeted delivery of genetic materials.
  • Focusing on RGD-functionalized systems for enhanced specificity.

Main Results:

  • RGD-functionalized vectors show potential for targeted delivery to angiogenic endothelial cells.
  • These systems can facilitate efficient gene therapy for cancer.
  • Applications include antiangiogenic strategies to inhibit tumor progression.

Conclusions:

  • RGD-functionalized nonviral vectors represent a promising approach for targeted cancer gene therapy.
  • This strategy holds significant potential for improving antiangiogenic therapy outcomes.
  • Further research is warranted to optimize these systems for clinical application.

More Related Videos

Study of Viral Vectors in a Three-dimensional Liver Model Repopulated with the Human Hepatocellular Carcinoma Cell Line HepG209:13

Study of Viral Vectors in a Three-dimensional Liver Model Repopulated with the Human Hepatocellular Carcinoma Cell Line HepG2

Published on: October 24, 2016

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...